NATURAL BIOACTIVE COMPOUND FROM MORINGA OLEIFERAAGAINST CANCER BASED ON IN SILICO SCREENING

Authors

  • Ardini Pangastuti PostgraduateProgramm of Biology Education, State University of Malang, Malang, Indonesia
  • Ihya Fakhrurizal Amin Student in Senior High School 3 Malang, Indonesia
  • Ahya Zhilalikbar Amin Student in Senior High School 3 Malang, Indonesia
  • Mohammad Amin Lecture of Biological Education, State University of Malang, Malang, Indonesia

DOI:

https://doi.org/10.11113/jt.v78.8328

Keywords:

Glycosiltransferase, Moringa oleifera, niazimicin, reverse docking

Abstract

Cancer is the leading cause of death in the world. More than 10 million people worldwide are expected to be diagnosed with cancer, a disease commonly believed to be preventable. Moringa oleifera is one of the well known as a local plant as food and health plant in Indonesia. Anticancer is one of potential treatment found in Moringa oleifera seed, leaves, and pods extracts. This study aimed to discover natural bioactivity compound from Moringa oleifera for anticancer. Niazimicin is one of bioactive compound found in Moringa oleifera reported have potent antitumor promoting activity. The bioinformatics tool used in this study were: Pubchem compound database, protein target prediction database Pharmmapper and Chemmapper, molecular docking software PyRx 0,8, ligand docking and binding site analysis with PyMOL and LigPlus software. To check for compound’s drug-likeness were applied using DruLiTo software. Based on our previous steps, we found that niazimicin interacted with glycosyltransferase via hydrogen bond and hydrophobic interactions. Niazimicin is the best Glycosiltransferase inhibitor based on binding afinity (-7,3 kcal/mol) that is more negative than existing glycosiltransferase inhibitor, such as tert-Butyl 4-(5-formyl-2-thienyl)piperazine-1-carboxylate, sialic acid and fucose. According to Lipinski's rule parameter we discover that Niazimicin is a potential anticancer drug.

References

Anand, Preetha, Kunnumakara, Ajaikumar; Sundaram, Chitra, Harikumar, Kuzhuvelil, Tharakan, Sheeja, Lai, Oiki, Sung, Bokyung & Aggarwal, Bharat. 2008. Cancer is a Preventable Disease that Requires Major Lifestyle Changes. Pharmaceutical Research. 25(9): 2097-2116.

Habibie, Rizky, Martatino, Ingga Y & Widodo, Putranto. 2013. Future of Health Plant: High Light of Moringa oleifera Using in Indonesia. Health & Medicine, Technology.

Purwal, L., Pathak, A. K. & Jain, U. K. 2010. In Vivo Anticancer Activity Of The Leaves And Fruits Of Moringa Oleifera On Mouse Melanoma. Pharmacologyonline. 1: 655-665.

Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., Zheng, S., Li, H., & Jiang, H. 2010. PharmMapper Server: A Web Server For Potential Drug Target Identification Using Pharmacphore Mapping Approach. Nucleic Acids Res. 38: W609-14.

Gong, J., Cai, C., Liu, X., Jiang, H., Gao, D., & Li, H. 2013. ChemMapper: A Versatile Web Server For Exploring Pharmacology And Chemical Structure Association Based On Molecular 3D Similarity Method. Bioinformatics. 29(14): 1827-9.

Sharma, Arun, Dutta, Prasun, Sharma, Maneesh, et al. 2014. BioPhyMol: A Drug Discovery Community Resource On Anti-Mycobacterial Phytomolecules And Plant Extacts. Journal of Cheminformatics. 6(46): 1-10.

He, M., et al. 2014. A Genome Wide Association Study Of Genetic Loci That Influence Tumour Biomarkers Cancer Antigen 19-9, Carcinoembryonic Antigen And Α Fetoprotein And Their Associations With Cancer Risk. Gut. 63(1): 143-51.

Gloster, T. M. & Vocadlo, D. J. 2012. Developing Inhibitors Of Glycan Processing Enzymes As Tools For Enabling Glycobiology. Nat Chem Biol. 8: 683-694.

Patani, N; Jiang, W & Mokbel K. 2008. Prognostic Utility Of Glycosyltransferase Expression In Breast Cancer. Cancer Genomics Proteomics. 5(6): 333-40.

Vanconcelos-dos-santos, Andeia, Oliveira, Isadora, Lucena, Miguel, et al. 2015. Biosynthetic Machinery Involved In Aberrant Glycosylation: Promising Targets For Developing Of Drugs Against Cancer. Frontiers in Oncology. 5(138): 1-23.

Sun, X. L. 2013. Glycosyltransferases as Potential Drug Targets. Medicinal Chemistry. 3(1): 1-2.

Kharkar, P; Warrier, Sona & Gaud, Ram. 2014. Reverse Docking: A Powerful Tool For Drug Repositioning And Drug Rescue. Future Medicinal Chemistry. 6(3): 333-342.

Rillahan, C. D., Antonopoulos, A., Lefort, C. T., Sonon, R., Azadi, P., Ley, K., Dell, A., Haslam, S. M., & Paulson, J. C. 2012. Global Metabolic Inhibitors of Sialyl- and Fucosyltransferases. Nat Chem Biol. 8(7):661-668.

Descroix, K., Pesnot, T., Yoshimura, Y., Gehrke, S. S., Wakarchuk, W., et al. 2012. Inhibition of Galactosyltransferases By A Novel Class Of Donor Analogues. J Med Chem. 55: 2015-2024.

Gloster, T. M., Zandberg, W. F., Heinonen, J. E, Shen, D. L., et al. 2011. Hijacking A Biosynthetic Pathway Yields A Glycosyltransferase Inhibitor Within Cells. Nat Chem Biol. 7: 178-181.

Downloads

Published

2016-04-18

Issue

Section

Science and Engineering

How to Cite

NATURAL BIOACTIVE COMPOUND FROM MORINGA OLEIFERAAGAINST CANCER BASED ON IN SILICO SCREENING. (2016). Jurnal Teknologi, 78(5). https://doi.org/10.11113/jt.v78.8328